AMEH - Apollo Medical Q2 GAAP EPS beats estimate co reiterates FY 2022 revenue guidance
- Apollo Medical press release ( NASDAQ: AMEH ): Q2 GAAP EPS of $0.25 beats by $0.05 .
- Revenue of $269.7M (+53.6% Y/Y).
- Reiterates FY 2022 revenue guidance of $1.055B to $1.085B.
- Reiterated FY 2022 adj. EBITDA guidance of $136M to $166M.
For further details see:
Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance